Apollomics Inc. (APLM)

NASDAQ

$20.55

$-0.25

(-1.26%)

Pre-Market

Apollomics Inc. (APLM) Live Price Chart

Last updated: ⁦2026-10-29 12:44:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Apollomics Inc. (APLM) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $20.55, with a market capitalization of $58.01M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $10.01 to $28.29. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$58.01M
Open	$19.78
Day's High	$4,900.00
Day's Low	$3.66
Previous Close	$19.90
Volume	26.83K
Average Volume	17.22K
P/E Ratio	--
52-Week High	$28.29
52-Week Low	$10.01
Dividend Yield	--
Earnings Date	--

Apollomics Inc. (APLM) Pre-Market Stock Price

Apollomics Inc. (APLM) is trading at $19.76 in pre-market trading as of 2026-10-28 23:31:00, down 0.70% ($0.14) from the previous close of $19.90

Pre-market trading shows how investors are pricing APLM before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Apollomics Inc. (APLM) 7-Day Stock Price Change

Over the past seven days, Apollomics Inc. (APLM) moved from $21.10 to $20.55, representing a decline of 2.62% ($0.55).

The stock traded between $19.01 and $23.40 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.

The average daily volume was 20.52 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

APLM 52-Week Price Position

Position in Range: 57.7%

52W Low$10.01

52W High$28.29

APLM is currently trading at $20.55, placing it 57.7% of the way from its 52-week low of $10.01 to its 52-week high of $28.29. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Apollomics Inc. (APLM)?

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia. Company has three new immuno-oncology product candidates: APL-501, APL-502 and APL-801 include mono-specific and bi-specific antibodies to fight against cancer.

Apollomics Inc. Information

Employees	15
Exchange	NASDAQ
Company Website	https://www.apollomicsinc.com

How to Buy Apollomics Inc. (APLM) Stock on MEXC

Eligible investors can buy real shares of Apollomics Inc. (APLM) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for APLM and Place Your Order

Open the RealStocks trading page and search for APLM. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Apollomics Inc. (APLM) stock price today?

Apollomics Inc. (APLM) is currently trading at $ 20.55, up 3.26% ($0.65) from the previous close of $ 19.90. Intraday prices update in real time during regular trading hours.

2.Is APLM stock going up or down today?

As of 2026-10-28 23:31:00, APLM is trading at $ 20.55, up 3.26% ($0.65) from its previous close of $ 19.90. The stock has traded between $ 3.66 and $ 4,900.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is APLM pre-market price?

As of 2026-10-28 23:31:00, APLM is trading at $ 19.76 in pre-market trading, down 0.70% ($0.14) from the previous close of $ 19.90. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is APLM after-hours price?

As of 2026-10-28 23:31:00, APLM is trading at $ 20.56 in after-hours trading, up 3.32% ($0.66) from the regular-session close of $ 19.90. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is APLM stock trading now?

APLM trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does APLM sit relative to its 52-week high and low?

Over the past 52 weeks, APLM has traded between a low of $ 10.01 and a high of $ 28.29. At $ 20.55, the stock is positioned 57.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Apollomics Inc. in?

Apollomics Inc. (APLM) operates in the -- sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Apollomics Inc.'s market capitalization and where is it listed?

Apollomics Inc. is listed on the NASDAQ exchange with a market capitalization of $ 58.01M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is APLM valued in terms of P/E ratio and EPS?

APLM trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Apollomics Inc. pay a dividend?

Apollomics Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.